Oracle (Redwood Shores, CA) announced the release of 

, its integrated pharmacovigilance suite that helps users meet regulatory compliance by supporting drug safety processes across the R&D spectrum, from clinical development through post-marketing. 

The new release includes  enhancements to Oracle Argus Safety (advanced reporting features, including dashboards and metrics, and new automation functionality for  case processing), 

 “Health sciences organizations recognize that they can significantly reduce the costs and risks associated with bringing drugs and devices to market by identifying and effectively managing safety issues early,” said Neil de Crescenzo, Senior Vice President and General Manager, Oracle Health Sciences. “The Oracle Argus Safety Suite has proven effective in helping organizations of all sizes ensure regulatory compliance and improve the overall safety of therapies.” 